Terms: = Liver cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Clinical Outcome
145 results:
1. Comparison of Microwave and Radiofrequency ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
[TBL] [Abstract] [Full Text] [Related]
2. Metastatic site and clinical outcome of patients with deficient mismatch repair metastatic colorectal cancer treated with an immune checkpoint inhibitor in the first-line setting.
Saberzadeh-Ardestani B; Jones JC; McWilliams RR; Tougeron D; Halfdanarson TR; Guimbaud R; Hubbard JM; Flecchia C; Shi Q; Alouani E; Sonbol MB; Ticku J; Jin Z; Taieb J; Sinicrope FA
Eur J Cancer; 2024 Jan; 196():113433. PubMed ID: 37979306
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of Baseline
Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
[TBL] [Abstract] [Full Text] [Related]
4. Transarterial chemoembolization
Yang B; Yuan M; Yang T; Liao Z; Wu H
Oncol Res; 2022; 30(1):23-33. PubMed ID: 37304009
[TBL] [Abstract] [Full Text] [Related]
5. 17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease.
Wang MX; Peng ZG
Pharmacol Ther; 2023 Jun; 246():108428. PubMed ID: 37116587
[TBL] [Abstract] [Full Text] [Related]
6. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
Feng NN; Du XY; Zhang YS; Jiao ZK; Wu XH; Yang BM
Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
[TBL] [Abstract] [Full Text] [Related]
7. Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss.
Yip TC; Wong VW; Lai MS; Lai JC; Hui VW; Liang LY; Tse YK; Chan HL; Wong GL
J Hepatol; 2023 Mar; 78(3):524-533. PubMed ID: 36463985
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of Protumorigenic Effects after Image-Guided Radiofrequency ablation of Hepatocellular Carcinoma Using Biomarkers.
Stechele M; Wildgruber M; Markezana A; Kästle S; Öcal E; Kimm MA; Alunni-Fabbroni M; Paldor M; Haixing L; Salvermoser L; Pech M; Powerski M; Galun E; Ricke J; Goldberg SN
J Vasc Interv Radiol; 2023 Sep; 34(9):1528-1537.e1. PubMed ID: 36442741
[TBL] [Abstract] [Full Text] [Related]
9. Treatment of hepatitis delta and HIV infection.
Soriano V; de Mendoza C; Treviño A; Ramos-Rincón JM; Moreno-Torres V; Corral O; Barreiro P
Liver Int; 2023 Aug; 43 Suppl 1():108-115. PubMed ID: 35748639
[TBL] [Abstract] [Full Text] [Related]
10. Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C-Registry.
Tacke F; Klinker H; Boeker KHW; Merle U; Link R; Buggisch P; Hüppe D; Cornberg M; Sarrazin C; Wedemeyer H; Berg T; Mauss S;
Hepatol Commun; 2022 Sep; 6(9):2488-2495. PubMed ID: 35666055
[TBL] [Abstract] [Full Text] [Related]
11. Impact of Modern Management Strategies on the clinical outcome of Patients With Low Rectal cancer - A Retrospective, Monocentric Cohort Study.
Karam E; Sindayigaya R; Giger-Pabst U; Gabriel M; Michot N; Courtot L; Tabchouri N; Moussata D; Lecomte T; Chapet S; Calais G; Bourlier P; Salamé E; Ouaissi M
Anticancer Res; 2022 Apr; 42(4):1949-1963. PubMed ID: 35347015
[TBL] [Abstract] [Full Text] [Related]
12. Port-Site Metastases in Incidentally Detected Carcinoma Gall Bladder: Role of 18F-FDG PET/CT and Patient outcome.
Saini VK; Hassan A; Singh AK; Ora M; Gambhir S
J Gastrointest Cancer; 2022 Mar; 53(1):16-21. PubMed ID: 35067855
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcome and Utilization Profiles Among Latent Groups of High-Risk Patients: Moving from Segmentation Towards Intervention.
Hutchins F; Thorpe J; Maciejewski ML; Zhao X; Daniels K; Zhang H; Zulman DM; Fihn S; Vijan S; Rosland AM
J Gen Intern Med; 2022 Aug; 37(10):2429-2437. PubMed ID: 34731436
[TBL] [Abstract] [Full Text] [Related]
14. Differential role of residual metabolic tumor volume in inoperable stage III NSCLC after chemoradiotherapy ± immune checkpoint inhibition.
Unterrainer M; Taugner J; Käsmann L; Tufman A; Reinmuth N; Li M; Mittlmeier LM; Bartenstein P; Kunz WG; Ricke J; Belka C; Eze C; Manapov F
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1407-1416. PubMed ID: 34664091
[TBL] [Abstract] [Full Text] [Related]
15. PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung cancer.
Smit J; Borm FJ; Niemeijer AN; Huisman MC; Hoekstra OS; Boellaard R; Oprea-Lager DE; Vugts DJ; van Dongen GAMS; de Wit-van der Veen BJ; Thunnissen E; Smit EF; de Langen AJ
J Nucl Med; 2022 May; 63(5):686-693. PubMed ID: 34385342
[TBL] [Abstract] [Full Text] [Related]
16. The association between oral health status and the clinical outcome of cirrhotic patients on the waiting list for liver transplantation.
Wu JH; Lee CY; Chang WT; Wu PH; Chen LA; Huang JW; Su WL; Kuo KK
Kaohsiung J Med Sci; 2021 Oct; 37(10):910-917. PubMed ID: 34288387
[TBL] [Abstract] [Full Text] [Related]
17. Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib.
Fujii Y; Ono A; Hayes CN; Aikata H; Yamauchi M; Uchikawa S; Kodama K; Teraoka Y; Fujino H; Nakahara T; Murakami E; Miki D; Okamoto W; Kawaoka T; Tsuge M; Imamura M; Chayama K
J Exp Clin Cancer Res; 2021 Jun; 40(1):215. PubMed ID: 34174931
[TBL] [Abstract] [Full Text] [Related]
18. Molecular characterization of hepatitis B virus basal core promoter and precore region of isolates from chronic hepatitis B patients.
Ahmad I; Ahmad K
J Pak Med Assoc; 2021 Jun; 71(6):1575-1582. PubMed ID: 34111075
[TBL] [Abstract] [Full Text] [Related]
19. Pretreatment metastatic growth rate determines clinical outcome of advanced melanoma patients treated with anti-PD-1 antibodies: a multicenter cohort study.
Wagner NB; Lenders MM; Kühl K; Reinhardt L; André F; Dudda M; Ring N; Ebel C; Stäger R; Zellweger C; Lang R; Paar M; Gussek P; Richtig G; Stürmer SH; Kimeswenger S; Oellinger A; Forschner A; Leiter U; Weide B; Gassenmaier M; Schraag A; Klumpp B; Hoetzenecker W; Berking C; Richtig E; Ziemer M; Mangana J; Terheyden P; Loquai C; Nguyen VA; Gebhardt C; Meier F; Diem S; Cozzio A; Flatz L; Röcken M; Garbe C; Eigentler TK
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33986126
[TBL] [Abstract] [Full Text] [Related]
20. Stathmin expression in metastatic colorectal cancer.
Leiphrakpam PD; Lazenby AJ; Smith LM; Brattain MG; Are C
J Surg Oncol; 2021 May; 123(8):1764-1772. PubMed ID: 33765336
[TBL] [Abstract] [Full Text] [Related]
[Next]
